Pylopass MONO for H. pylori
Pylopass™ for Helicobacter pylori infection.
Our Pylopass MONO capsules contain the patented raw material Pylopass™ - an inactivated Lactobacillus reuteri lactic acid bacterium strain. This bacterial strain is used for the dietary management of Helicobacter pylori infections. Without side effects!
Item number:
PY-MO-60
€32.00
Content:
0.023
(€1,391.30
/ 1 Kilogramm)
Prices incl. VAT Shipping costs
Quantity
Unit price
From
1
€32.00
€1,391.30
/ 1
From
3
€29.00
€1,260.87
/ 1
-9.4 %
From
6
€27.00
€1,173.91
/ 1
-15.6 %
Total:
The most important facts at a glance
Allergens
gluten free
lactose-free
vegan
GMO-free
without undesirable additives
without magnesium stearate
sugar free
Ingredients
Ingredients: Lactobacillus reuteri (DSM17648, inactivated), bulking agent: rice flour, coating agent: hydroxypropyl methylcellulose (capsule shell)
2 capsules contain:
- 20 billion (400 mg) PylopassTM Lactobacillus reuteri DSM17648 (inactive)
Origin Lactobacillus reuteri (DSM17648, inactivated): Denmark
Origin rice flour: Germany
Consumption recommendation
Pylopass™ MONO is authorised for the dietary management of Helicobacter pylori infections.
Recommended dosage: Take 2x 1 capsule daily with liquid.
Once opened, the product is stable until the end of the best-before date (see label).
Take the product with a meal.
Notes
Pylopass™ MONO is a food for special medical purposes (balanced diet) for the dietary management of Helicobacter pylori infections. The recommended daily intake must not be exceeded. Keep out of the reach of children. Store in a dry, cool place away from light.
PZN Germany 14210215 / PZN Austria 4851284
Laboratory analysis
Product information
Pylopass™: Natural support for stomach problems caused by H. pylori
Infection with Helicobacter pylori is now the most common bacterial infectious disease worldwide after tooth decay, affecting around half of the world's population. Every second to third German suffers from stomach complaints caused by Helicobacter pylori. The cause and diagnosis of H. pylori is often only found after detailed examinations and therefore this disease often remains undetected for a long time.
In some cases there are no symptoms or no symptoms worth mentioning, while in others the infection leads to a severe illness. Presumably, certain conditions in the stomach cause the bacterium to multiply excessively and only then cause problems. A temporarily too high pH value in the stomach (too little acid) could, for example, be a reason for the excessive Helicobacter proliferation in some people. This is because a healthy stomach acid level puts Helicobacter pylori in its place.
Long-lasting stomach pain, pressure in the upper abdomen, fasting pains, a constant feeling of fullness, heartburn, belching, vomiting or recurring nausea, loss of appetite and anaemia as well as B12 deficiency can be symptoms of an infection with Helicobacter pylori. The long-term consequences are then often gastritis, gastric and duodenal cancer and much more.
Pylopass™ is used for the dietary management of Helicobacter pylori infections. This product contains the natural but inactivated lactic acid bacterium Lactobacillus reuteri DSM17648. When inactivated, this particular bacterial strain is able to bind to several Helicobacter bacteria in a matter of seconds without affecting the natural intestinal bacteria. The Helicobacter bacteria bound to this unique Pylopass™ lactic acid are excreted in the stool.
Several studies have demonstrated the ability of Pylopass™ to eliminate H. pylori bacteria from the body and show that the quality of life of users improved significantly after just 2 weeks.
What makes Pylopass™ special
- resistant to stomach acid
- free of side effects
- does not alter the body's own intestinal flora
- insensitive to heat
- allergen-free
- suitable for children
Studies on Pylopass™
- Buckley et al. (2018) The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study
- Kornienko et al (2020) Gastric opportunities in HP eradication in children
- Uspensky et al. (2016) Evolution in eradication therapy of HP -associated diseases: beyond the standards?
- Paralova et al. (2015) An innovative approach in the treatment of H. pylori infection in children.
- Bordin et al. (2015) The efficiency and safety of probiotic bacteria Lactobacillus reuteri DSMZ17648 in patients infected with Helicobacter pylori, who haven't absolute indications for eradication therapy: results of the study
- Holz et al (2014): Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: a pilot study
- Mehling and Busjahn (2013) Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans
- Parth K (2021) Efficacy L reuteri triple therapy eradication.
Reviews
Login
Questions and answers
How long should I take Pylopass MONO if I have a Helicobacter pylori infection?
Ihre Vorteile bei SinoPlaSan
Premium food supplements
Manufactured in our own production facility in Germany
High-quality ingredients, no unnecessary additives
Developed by experts, regularly tested by external laboratories
Clean label, optimum product compatibility
Latest blog articles
That's why omega-3 fatty acids are crucial for your health
Why omega-3 fatty acids are crucial for health and how high-quality algae oil works as a vegan alternative!
Important dietary supplements for a vegan diet
You should take these food supplements when following a vegan diet to prevent a deficiency.
Fit and healthy through the winter season
How vitamin D, omega-3, zinc, vitamin C, probiotics, iron & B12 can support your health in winter!
Storing food supplements correctly
How light, temperature and humidity affect the quality of food supplements.
